Stewart McCallum
2016
In 2016, Stewart McCallum earned a total compensation of $681K as Chief Medical Officer at Recro Pharma, a 8% decrease compared to previous year.
Compensation breakdown
| Bonus | $43,000 |
|---|---|
| Non-Equity Incentive Plan | $172,000 |
| Salary | $430,000 |
| Other | $36,034 |
| Total | $681,034 |
McCallum received $430K in salary, accounting for 63% of the total pay in 2016.
McCallum also received $43K in bonus, $172K in non-equity incentive plan and $36K in other compensation.
Rankings
In 2016, Stewart McCallum's compensation ranked 10,006th out of 14,075 executives tracked by ExecPay. In other words, McCallum earned more than 28.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,006 out of 14,075 | 29th |
Division Manufacturing | 3,859 out of 5,486 | 30th |
Major group Chemicals And Allied Products | 1,357 out of 1,900 | 29th |
Industry group Drugs | 1,084 out of 1,543 | 30th |
Industry Pharmaceutical Preparations | 850 out of 1,173 | 28th |
Source: SEC filing on March 23, 2018.
McCallum's colleagues
We found three more compensation records of executives who worked with Stewart McCallum at Recro Pharma in 2016.